Neovasc Receives FDA Approval to Initiate Pivotal Reducer Trial

6 November 2017

Neovasc Inc. announced that it has received approval of the U.S. Food and Drug Administration ("FDA") to initiate the COSIRA-II IDE pivotal clinical trial.  The trial's purpose w